It is widely prescribed by healthcare professionals for patients suffering from peripheral neuropathy, weakness, burning feet syndrome, and nerve-related complications caused by diabetes
In transected rat Achilles tendon models, BPC-157 treatment resulted in accelerated recovery with increased load to failure, superior functional scores, enhanced cellular infiltration for repair, better collagen fiber organization, and smaller persistent defects compared to untreated controls
The United Kingdom National Quality Assessment Scheme for Haematinic Assays warns against false B12 results and the risk of neurological damage: In the event of any discordance between clinical findings of B12 deficiency and a normal B12 laboratory result, then treatment should not be delayed
Practical scenarios: Drinking tonight: inject BPC-157 in the morning Drank last night: inject BPC-157 as usual the next day Spontaneous drinks: do not skip your scheduled injection
This once slow process has radically accelerated
B12 may lower cervical cancer risk and reduce risk of heart disease